FdaApplication
BLA 761158
Identifiers
- fda_app_no: BLA761158
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline Intellectual Property Development Ltd. England |
| application_type | BLA |
| approval_date | 2020-08-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BLENREP | — | 100MG | For Injection |
1 product